A nationwide prospective surveillance study in Israel to document pediatric invasive infections, with an emphasis on Haemophilus influenzae type b infections

Pediatric Infectious Disease Journal

Volumn 17, Issue 9 SUPPL., 1998, Pages

  Dagan, Ron ^a   Fraser, Drora ^a   Greif, Zvi ^b   Keller, Nathan ^c   Kaufstein, Miriam ^d   Shazberg, Gila ^e   Schlesinger, Menachem ^f  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b Nahariya Hospital Israel   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d HILLEL YAFFE MEDICAL CENTER   (Israel)

^e BIKUR CHOLIM HOSPITAL   (Israel)

^f BARZILAI MEDICAL CENTER   (Israel)

Author keywords

Epidemiology; Haemophilus influenzae; Haemophilus influenzae type b; Israel; Vaccine

Indexed keywords

DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; OUTER MEMBRANE PROTEIN; TETANUS TOXOID;

BACTERIAL INFECTION; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DRUG EFFECT; DRUG EFFICACY; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; INCIDENCE; INFANT; ISRAEL; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

CHILD, PRESCHOOL; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; INFANT; ISRAEL; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; VACCINATION; VACCINES, CONJUGATE;

EID: 0031656203     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199809001-00025     Document Type: Conference Paper

References (32)

1. Ward J, Leiberman JM, Cochi SL. Haemophilus influenzae vaccines. In: Plotkin SA, Mortimer EA, eds. Vaccines. 2nd ed. Philadelphia: Saunders, 1994:337-86.
2. Progress toward elimination of Haemophilus influenzae type b disease among infants and children: United States, 1987-1995. US Department of Health and Human Services/Public Health Services, CDC. MMWR October 25, 1996;45(42): 901-6.
3. Peltola H, Virtanen M. Systemic Haemophilus influenzae infection in Finland. Clin Pediatr 1984;23:275-80.
4. Claesson BA, Trollfors B, Ekström-Jodal B, et al. Incidence and prognosis of acute epiglottitis in children in a Swedish region. Pediatr Infect Dis 1984;3:5334-8.
5. Hanna JN. The epidemiology of invasive Haemophilus influenzae infections in children under five years of age in the Northern territory: a three-year study. Med J Aust 1990;152: 234-40.
6. Coulehan JL, Michaels RH, Hallowell CH, Schults R, Welty TK, Kuo JS. Epidemiology of Haemophilus influenzae type B disease among Navajo Indians. Public Health Rep 1984;99: 404-9.
7. Ferreccio C, Ortiz E, Astroza L, Rivera C, Clemens J, Levine MM. A population-based retrospective assessment of the disease burden resulting from invasive Haemophilus influenzae in infants and young children in Santiago, Chile. Pediatr Infect Dis J 1990;9:488-94.
8. Bijlmer HA. World-wide epidemiology of Haemophilus influenzae meningitis; industrialized versus non-industrialized countries. Vaccine 1991;9(Suppl):5-9.
9. Mulholland EK, Hoestermann A, Ward JI, Maine N, Ethevenaux C, Greenwood BM. The use of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine mixed with diphtheria-tetanus-pertussis vaccine in Gambian infants. Vaccine 1996;14:905-9.
10. Munson RS Jr, Kabeer MH, Lenoir AA, Granoff DM. Epidemiology and prospects for prevention of disease due to Haemophilus influenzae in developing countries. Rev Infect Dis 1989;11(Suppl 3):5:88-97.
11. Peltola H, Rod T, Jónsdóttir K, Böttiger M, Coolidge JAS. Life-threatening Haemophilus influenzae infections in Scandinavia: a five-country analysis of the incidence and the main clinical and bacteriologic characteristics. Rev Infect Dis 1990; 12:708-15.
12. Cochi SL, Broome CV, Hightower AW. Immunization of U. S. children with Haemophilus influenzae type b polysaccharide vaccine: a cost effectiveness model of strategy assessment. JAMA 1985;253:521-9.
13. Dajani AS, Asmar BI, Thirumoorthi MC. Systemic Haemophilus influenzae disease: an overview. J Pediatr 1979;94: 355-64.
14. Takala AK, Eskola J, Peltola H, Mäkelä PH. Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine. Pediatr Infect Dis J 1989;8: 297-302.
15. Tudor-Williams G, Frankland J, Isaacs D, et al. Haemophilus influenzae type b disease in the Oxford region. Arch Dis Child 1989;64:517-9.
16. Gervaix A, Suter S. Epidemiology of invasive Haemophilus influenzae type b infections in Geneva, Switzerland, 1976 to 1989. Pediatr Infect Dis J 1991;10:370-4.
17. Broome CV. Epidemiology of Haemophilus influenzae type b infections in the United States. Pediatr Infect Dis J 1987;6: 779-82.
18. Claesson BA, Trollfors B, Jodal U, Rosenhall U. Incidence and prognosis of Haemophilus influenzae meningitis in children in a Swedish region. Pediatr Infect Dis 1984;3:35-9.
19. Spanjaard L, Bol P, Ekker W, Zanen HC. The incidence of bacterial meningitis in the Netherlands: a comparison of three registration systems, 1977-82. J Infect 1985;11:259-68.
20. Cadoz M, Denis F, Diop Mar I. Etude épidémiologique des cas de méningites purulentes hospitalisés à Dakar pendant la décennie 1970-1979. Bull WHO 1981;59:575-84.
21. Guirguls N, Hafez K, El Kholy MA, Robbins JB, Gotschlich EC. Bacterial meningitis in Egypt: analysis of CSF isolates from hospital patients in Cairo, 1977-78. Bull WHO 1983;61: 517-24.
22. Autret E, Diop Mar I, Denis F, Chiron JP, Cadoz M, Sow A. Méningites purulentes à Haemophilus influenzae b: analyse de 248 observations dakaroises. Med Afr Noire 1979;26: 861-9.
23. Dagan R, The Israeli Pediatric Bacteremia and Meningitis Group. A two-year prospective, nationwide study to determine the epidemiology and impact of invasive childhood Haemophilus influenzae type b infection in Israel. Clin Infect Dis 1992;15:720-5.
24. Trollfors B, Claesson BA, Strangert K, Taranger J. Haemophilus influenzae meningitis in Sweden 1981-1983. Arch Dis Child 1987;62:1220-3.
25. Bol P. Epidemiology of Haemophilus influenzae meningitis in children 0-6 years of age. Thesis, The University of Amsterdam, 1987:125-40.
26. Reinert P, Livartowski A, Debernat H, Guyot C, Boucher J, Carrere C. Epidemiology of Haemophilus influenzae type b disease in France [Abstract 267]. In: Abstracts of the Fifth European Congress of Clinical Microbiology and Infectious Diseases, Oslo, Norway, 1991:49.
27. Ginsberg GM, Kassis I, Dagan R. Cost benefit analysis of Haemophilus influenzae type b vaccination programme in Israel. J Epidemiol Community Health 1993;47:485-90.
28. Mohle-Boetani JC, Ajello G, Breneman E, et al. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Pediatr Infect Dis J 1993;12:589-93.
29. Murphy TV, Pastor P, Medley F, Osterholm MT, Granoff DM. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J Pediatr 1993;122:517-23.
30. Takala AK, Santosham M, Almeido-Hill J, et al. Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children. Pediatr Infect Dis J 1993;12:593-9.
31. Takala AK, Eskola J, Leinonen M, et al. Reduction in oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis 1991;164:982-6.
32. Barbour ML, Mayon-White RT, Crook DW, Coles C, Moxon ER. The influence of Haemophilus influenzae type b conjugate vaccine (PRP-T) on oropharyngeal carriage of Haemophilus influenzae type b in infants under 12 months of age [Abstract 304]. In: Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, October, 1993. Washington, DC: American Society for Microbiology, 1993:175.